Ivashko-Pachima, Y., Maor-Nof, M., & Gozes, I. (2019). NAP (davunetide) preferential interaction with dynamic 3-repeat Tau explains differential protection in selected tauopathies. PLoS One.
Dyfyniad Arddull ChicagoIvashko-Pachima, Yanina, Maya Maor-Nof, and Illana Gozes. "NAP (davunetide) Preferential Interaction With Dynamic 3-repeat Tau Explains Differential Protection in Selected Tauopathies." PLoS One 2019.
Dyfyniad MLAIvashko-Pachima, Yanina, Maya Maor-Nof, and Illana Gozes. "NAP (davunetide) Preferential Interaction With Dynamic 3-repeat Tau Explains Differential Protection in Selected Tauopathies." PLoS One 2019.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.